Therefore, this strategy of targeting LRP/LR has a 4‐fold function in impeding key cancer hallmarks in the lung cancer cells, which therefore has the potential for improving the prognosis of those suffering from lung cancer. The gene discussed is RPSA; the disease is cancer.